drugset

drugset / Trial / NCT00365898

Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

NCT00365898 ↗

Phase 3 Terminated 380 enrolled Purdue Pharma LP

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to assess the efficacy and safety of 8 mg Hydromorphone Hydrochloride Extended-Release.

Timeline

Start: 2005-07
Primary completion: —
Completion: 2005-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Hydromorphone	Other / unclassified	8 mg	—

Indications